Article info
PDFVasculitis
Original article
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
- Correspondence to Dr Vítor Teixeira,Vasculitis and Lupus Clinic, Addenbrooke's Hospital, Cambridge, UK; vitor.as.teixeira{at}gmail.com
Citation
Efficacy and safety of rituximab in the treatment of eosinophilic granulomatosis with polyangiitis
Publication history
- Received January 14, 2019
- Revision received May 6, 2019
- Accepted May 15, 2019
- First published June 5, 2019.
Online issue publication
June 05, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/.